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Recruitment and Biological Consequences of Histone Modification
of H3K27me3 and H3K9me3

Abstract
Two histone marks, H3K27me3 and H3K9me3, are well
known for their repressive roles in the genic and nongenic
regions of metazoan genomes. Several protein complexes
are known to be responsible for generating these marks,
including polycomb repression complex 2 and several
H3K9 methylases. Recent studies have shown that the
targeting of these histone-modifying complexes within
mammalian genomes may be mediated through several
DNA-binding proteins, including AEBP2, JARID2, and
YY1. In this review, we discuss the potential targeting
mechanisms in light of the recent results that have been
derived from genome-wide chromatin immunoprecipitation sequencing data and the in vivo functions of these two
histone marks in light of the results derived from mouse
and human genetic studies.
Key Words: AEBP2; H3K9me3; H3K27me3; JARID2;
PRC2; YY1

Introduction

T

wo histone marks, H3K27me3 (trimethylation on Lys
27 of histone 3) and H3K9me3 (trimethylation on
Lys 9 of histone 3), are known for their roles related
to repression in the genic and nongenic regions of metazoan genomes. Several complexes are known to be responsible for generating these marks, including polycomb
group complexes and H3K9 methylases. However, the
mechanisms by which these complexes are targeted are not
well understood, although a number of hypotheses have
been proposed to explain these targeting mechanisms. One
mechanism would be through DNA-binding proteins, such
as JARID2 and AEBP2 for H3K27me3 and other DNAbinding proteins for H3K9me3, whereas the other mechanism
recently discovered and proposed would be through noncod-
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ing RNA (ncRNA1), which has been recently discovered
and proposed. In this review, we summarize and discuss
the first mechanism, a DNA-binding protein–mediated targeting mechanism, with the recent results that have been
derived from genome-wide chromatin immunoprecipitation sequencing (ChIP-Seq1) data, and we also discuss the
in vivo functions of these histone modification marks with
the data derived from mouse and human genetic studies.

Genome-Wide Distribution of Histone
Modiﬁcation Marks in Mammals
In the past several years, the genome-wide distribution of the
histone marks H3K27me3 and H3K9me3 has been analyzed
using ChIP techniques (Boyer et al. 2006; Lee et al. 2006;
Mikkelsen et al. 2007). From these studies, the following
conclusions about the genome-wide distributions of the two
histone modification marks can be derived.
First, although these two marks are recognized as repressive signals, these marks are found in different chromosomal
regions. H3K27me3 is detected preferentially in gene-rich
regions, which are traditionally defined as R-banding regions
by Giemsa staining (Pauler et al. 2009). In particular,
H3K27me3 is closely associated with a set of development
regulators, estimated to be about 500 genes, in embryonic
stem cells (Boyer et al. 2006; Lee et al. 2006). The list of
these genes includes Hox, Pax, and Sox gene family members, which are expressed during animal development, but
not in pluripotent embryonic stem cells. In a given gene, the
promoter region is usually marked with this histone modification, which shows CpG-rich sequence structures (Ku et al.
2008). In contrast, H3K9me3 is detected preferentially in
gene-poor regions, which are traditionally defined as
G-banding regions by Giemsa staining (Pauler et al. 2009).
These regions include satellite repeats in telomeres and pericentromeres, which show tandem repeat sequence structures. H3K9me3 is also detected in several families of
retrotransposons that have been amplified through RNAmediated mechanisms in vertebrate genomes. These retrotransposons with H3K9me3 include long interspersed DNA
that appear ≥3x throughout the article: ChIP-Seq, chromatin
immunoprecipitation sequencing; LTR, long terminal repeat; ncRNA,
noncoding RNA; PRC2, polycomb repression complex 2; RNAi, RNA
interference.
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Modifying Complexes
The H3K27me3 mark is established by a protein complex
called polycomb repression complex 2 (PRC21). In the past
decade, there have been numerous attempts to biochemically
purify PRC2 (Cao and Zhang 2004; Li et al. 2010; Pasini
et al. 2010; Peng et al. 2009; Shen et al. 2009). These studies
have shown that the following proteins are considered core
components for PRC2 based on their co-occurrence in the
independent purification attempts: EZH2, EED, SUZ12, and
RbAp46/48. EZH2 is the enzyme modifying H3K27, and
EED is the adaptor protein connecting all the other components. The exact molecular functions of SUZ12 and
RbAp46/48 are still unclear, but these two proteins are known
to enhance the enzymatic activity of EZH2. These core components of PRC2 are conserved among all the higher eukaryotes, including insects, vertebrates, and even plants
(Schuettengruber et al. 2007). This conservation is consistent
with the fact that H3K27me3 is one of the earliest histone
modification marks that have appeared during eukaryotes’
evolution. Besides the core components, recent studies
have also identified two DNA-binding proteins, AEBP2 and
JARID2, as PRC2-interacting components (Li et al. 2010;
Pasini et al. 2010; Peng et al. 2009; Shen et al. 2009). Similarly, the two DNA-binding proteins are also conserved among
all metazoans, ranging from insects to mammals (Kim et al.
2009; Liu and Montell 2001). According to the expression
profiles for the core components of PRC2, the majority of
proteins are highly expressed during early embryonic stages,
which is also consistent with the fact that H3K27me3 is the
most visible within the embryonic stem cells.
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The H3K9me3 mark is known to be generated by several enzymes, including SETDB1 (or ESET), SUV39H1,
SUV39H2, EHMT1 (GLP), and EHMT2 (G9A). This is in
stark contrast to the dominant role played by a single protein, EZH2, for the modification of H3K27me3. This difference may be because H3K9me3 is more global and
permanent than H3K27me3. Among these H3K9 methylases,
SUV39H1 and SUV39H2 are responsible for establishing
H3K9me3 in constitutive heterochromatic, pericentromeric, and telomeric regions (Peters et al. 2001). In contrast,
EHMT1 and EHMT2 are responsible for setting up
H3K9me3 in euchromatic regions (Tachibana et al. 2002).
On the other hand, SETDB1 is highly expressed in ES cells
and identified as a major regulator that is required for maintaining the pluripotency and self-renewal properties of ES
cells (Yeap et al. 2009; Yuan et al. 2009).
The H3K9 methylases have also been found to interact
with various proteins that may mediate recruitment to target
genes. First, the interacting partners for SETDB1 include
OCT4 in ES cells, suggesting that OCT4 might target
SETDB1 to numerous genomic loci in ES cells (Yeap et al.
2009; Yuan et al. 2009). SETDB1 also interacts with KAP-1,
which is also known as TRIM28 (tripartite motif–containing 28) (Schultz et al. 2002). KAP-1/TRIM28 is a transcriptional corepressor that interacts with a large number of
Kruppel-type zinc finger proteins found in vertebrate genomes, estimated to be more than 500 genes per genome
(Hamilton et al. 2003). Thus, the repressive function exerted
by the vast majority of Kruppel-type zinc finger proteins is
likely mediated through the interaction with KAP-1/TRIM28
and SETDB1, establishing H3K9me3 at the various target
loci of these Kruppel-type zinc finger proteins. Second, although the main target loci of SUV39H1 and SUV39H2 are
constitutive heterochromatic regions, these two methylases
are also known to interact with several proteins, such as
tumor suppressor RB and proto-oncoprotein EVI1, to repress individual gene loci (Ait-Si-Ali et al. 2004; Cattaneo
et al. 2008). Third, EHMT2 interacts with several DNAbinding proteins, including BLIMP-1, a regulator of primordial germ cell and B cell development, and GFI1, a
repressor of the cell cycle regulator p21Cip/EAF (Duan et al.
2005; Gyory et al. 2004). The major expression stages of
these H3K9 methylases are also early embryonic stages
similar to the core components of PRC2 for H3K27me3.
Similar to PRC2, the homologues of these H3K9 methylases
are also found in species ranging from insects to mammals,
confirming the evolutionary conservation of these methylases, as seen for the H3K27me3 mark.
As described earlier, the histone marks H3K27me3 and
H3K9me3 are very closely associated with DNA methylation, although a causal relationship between these two modifications has not been well understood. Consistent with this
close association with DNA methylation, several histone
methylases are known to interact with DNA methylation machineries. First, EZH2 is known to interact with DNMT3A,
DNMT3B, and DNMT1 (Viré et al. 2006). This interaction
appears to be critical for the repression of several PcG target
233
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elements and long terminal repeats (LTRs1) (Mikkelsen et al.
2007). H3K9me3 is also found in one particular gene family,
Kruppel-type zinc finger genes, the coding regions of which
show tandem repeat sequence structures (Blahnik et al. 2011).
Thus, H3K9me3 marks are overall closely associated with
tandem repeat sequences, whereas H3K27me3 marks are
associated with CpG-rich sequences.
Second, these histone marks are much more prevalent
during early embryonic stages, but they become less prevalent once embryonic stem cells are differentiated into somatic cells. In most genomic regions, these early histone
modification signals are changed into more permanent repression signals, such as DNA methylation (Meissner et al.
2008). This transition from histone to DNA modifications
also appears to be different between the two histone modification marks. In the case of H3K27me3, the majority of the
genomic regions with this mark is usually protected from
DNA methylation. On the other hand, the regions with
H3K9me3 are methylated in somatic cells. In summary,
H3K27me3 is regarded as a temporary repression signal that
is designed for controlling a set of development regulators. In
contrast, H3K9me3 is considered to be a permanent repression signal that is designed for the heterochromatin formation
of chromosomal regions with tandem repeat structures.

DNA-Binding Proteins and Targeting
Mechanisms
In Drosophila, small genomic fragments, that are 60 to 100
base pairs in length are known to bind and recruit PRC2, and
these fragments contain a cluster of DNA-binding sites for
several transcription factors—Pho (pleiohomeotic), Trl/GAF
(Trithorax-like, also known as GAGA factor), Psq (Pipsqueak),
Grh (Grainhead), and Zeste (Müller and Kassis 2006). Thus,
it is believed that these DNA-binding proteins may work
together to recruit PRC2. Similar mechanisms have been
proposed for the targeting of vertebrate PRC2, and two
DNA-binding proteins have been identified as the targeting
components for PRC2—AEBP2, and JARID2.
According to the results from ChIP experiments, both
proteins occupy a set of genomic loci that are bound by the
components of PRC2, further confirming that these two proteins are components of PRC2 (Kim et al. 2009; Li et al.
2010; Pasini et al. 2010; Peng et al. 2009; Shen et al. 2009).
Because these two proteins have DNA-binding capability,
these two proteins are predicted to function as targeting proteins for PRC2 (Figure 1). Both proteins are known to bind
to the genomic regions that contain CpG-rich and GAGA
motif–rich sequences (Kim et al. 2009; Peng et al. 2009).
The binding of the two proteins to CpG-rich sequences is
consistent with the fact that many H3K27me3-marked regions are in the CpG-rich promoter regions of development
regulators. The binding to GAGA motifs is also noteworthy
because similar motifs have been frequently identified as
part of polycomb responsive elements in Drosophila.
Although another DNA-binding protein called Trl/
GAF(GAGA factor) is known to bind to the GAGA motif in
flies, it will be interesting to test whether the insect homologues of AEBP2 and JARID2 also bind to the known polycomb responsive elements (Kim et al. 2009; Liu and Montell
2001). Several independent groups recently tested the potential
targeting function of JARID2 in mouse ES cells. Interestingly,
the results are somewhat inconsistent and controversial.
RNA interference (RNAi1)–based reduction of JARID2 resulted in either no change or somewhat increased levels of
H3K27me3 at the genomic loci that are targeted by PRC2
(Li et al. 2010; Peng et al. 2009; Shen et al. 2009). Although
more detailed studies remain to be done, this might be an
indication that JARID2 fine-tunes the levels of H3K27me3
for a given locus depending upon the development contexts
234

of cells and tissues. In mutant mice in which the transcription of Aebp2 was disrupted by a knock-in allele, the heterozygotes provided a similar result as seen in the RNAi-based
experiments of JARID2, causing increased levels of
H3K27me3 (Kim et al. 2011). This unexpected outcome is
also controversial at the moment. Nevertheless, there is no
doubt that the most obvious role of these two proteins for
PRC2 should be DNA binding, although the exact functional
context of this DNA binding remains to be investigated.
Several DNA-binding proteins are known to be associated with H3K9 methylases, including OCT4, RB, EVI1,
and GFI1, but the targeting function of these DNA-binding
proteins is likely limited to a small number of genes because
the vast majority of genomic loci marked with H3K9me3 are
tandem repeats. Also, the sequences of tandem repeats are
quite different from the binding motifs for these proteins.
If some DNA-binding proteins are involved in the targeting
of H3K9me3 to the tandem repeats, those proteins should
have binding capability with tandem repeats and also some
connection to H3K9me3 modification.
The protein YY1 fits these criteria based on the following reasons. First, YY1 is known to bind to ␥-satellite repeats, which are found as part of the pericentromeric repeats
of the mouse genome (Shestakova et al. 2004). Also, many
families of retrotransposons that are marked with H3K9me3,
such as long interspersed DNA elements and LTRs, have the
DNA-binding sites for YY1 (Khan et al. 2006; Satyamoorthy
et al., 1993). In fact, because many repeats tend to have the
DNA-binding sites for YY1, YY1 has been recognized as a
surveillance gene that represses transcriptional noise from
the vertebrate genomes (Shi et al. 1997). Second, according
to the results of YY1 ChIP-Seq data (Mendenhall et al.
2010), many binding sites for YY1 overlap with the peaks of
H3K4me3, but not with those of H3K27me3, which is somewhat contradictory to the long-standing prediction that YY1
may be a targeting protein for PRC2 (Atchison et al. 2003;
Wilkinson et al. 2006). It is, however, important to note that
two duplicated copies of YY1—REX1 and YY2 (Kim et al.
2007)—are known to interact with EED, a component of
PRC2. Thus, it is still possible that REX1 or YY2 might recruit PRC2 in ES cells (Garcia-Tuñon et al. 2011). Nevertheless, some YY1 binding sites overlap very well with the
peaks of H3K9me3. Furthermore, these genomic loci are
␥-satellites or retrotransposons, further supporting the possibility that YY1 might be involved in the targeting of
H3K9me3 to repetitive regions. Third, although YY1 has
long been predicted to be a targeting protein for PRC2, recent studies revealed that YY1 is a component of a newly
discovered polycomb complex, termed PhoRC (Pho repressive complex) (Klymenko et al. 2006). The main components of this complex are Pho (YY1 homologue in flies) and
another PcG protein called dSFMBT (Scm-related gene containing four MBT domains). SFMBT is a well-known repressor that recognizes H3K9me1 or K3K9me2 (Klymenko et al.
2006). This again supports the potential connection between YY1 and H3K9me3. Fourth, conditional knockdown
and knockout of YY1 during spermatogenesis result in a
ILAR Journal
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genes. Second, EHMT2 is also known to interact with
DNMT3A and DNMT3B through a protein subdomain
called ankyrin, independent from the SET domain that is
responsible for histone methylation (Epsztejn-Litman et al.
2008). Several studies involving biochemical purifications
indeed confirmed that isolated multiprotein complexes usually contain both histone and DNA methylases (Cedar and
Bergman 2009). This suggests that these complexes may
have dual functions for nucleosomes—methylation on both
histones and DNA (Cedar and Bergman 2009).

complete depletion of H3K9me3 in developing sperm in the
mouse (Wu et al. 2009). These in vivo data suggest that YY1
may be involved in establishing H3K9me3 in germ cells. In
summary, the observations described above strongly support
the idea that YY1 may be involved in the establishment of
H3K9me3.
In terms of detailed mechanisms, YY1’s role in
H3K9me3 is predicted to be quite different from the mechanism proposed for PRC2, by which DNA-binding proteins,
such as AEBP2 and JARID2, bind and recruit the histonemodifying complex. This model is impossible in the case of
H3K9me3 because there are a greater number of tandem repeats that need to be marked by H3K9me3 than available
protein molecules of YY1. One feasible scenario is illustrated in Figure 1. YY1 might bind to a small number of the
tandem repeats, but not all of them, and trigger the modification process of H3K9me3, which in turn spreads over all tandem repeats or retrotransposons. One candidate molecule for
transforming the initial marking to genome-wide marking
could be small RNAs. It is well known that small RNAs transcribed from pericentromeric repeats are used for recruiting
epigenetic machinery in plants, including H3K9 methylases
and DNA methylases (Martienssen et al. 2008). Although
similar mechanisms have not been identified so far for the
vertebrate genomes, recent studies revealed that small RNAs
derived from LTRs, such as Piwi-interacting RNA, are responsible for the transcriptional repression of LTRs and
Volume 53, Number 3/4
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other retrotransposons through DNA methylation (Saito et
al. 2006; Watanabe et al. 2006). It is still unclear how these
small RNAs are generated. However, given the ubiquitous
presence of YY1 binding sites in many retrotransposons, it is
feasible to predict that YY1 might trigger this initial transcription from the tandem repeats and LTRs, which are then
processed into Piwi-interacting RNAs. Finally, these Piwiinteracting RNAs might be used to recruit H3K9 methylases
to the tandem repeats or retrotransposons. Consistent with
this, some of the pericentromeric repeats in the mouse are
known to be transcribed in dividing cells (Lu and Gilbert
2007). In summary, several lines of evidence are consistent
with the hypothesis that YY1 is involved in establishing
H3K9me3, and thus it will be of great interest to test the
mechanism of YY1 as a triggering factor for the establishment of H3K9me3.
Besides the proposed targeting mechanisms for PRC2
and H3K9 methylases, several other mechanisms are also
likely, based on the following reasons. First, many loci with
H3K9me3 show tandem repeat sequence structures, but they
do not show any sequence similarity among themselves.
This suggests that the repeat structure itself, not the sequence, might be important for the recognition by H3K9
methylases. Second, recent studies have identified ncRNAs
as possible targeting molecules for PRC2. These exemplary
studies have been derived from the Hox and Xist loci (Rinn
et al. 2007; Zhao et al. 2008). The ncRNAs from these loci
235
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Figure 1 Potential targeting mechanisms for polycomb repression complex 2 (PRC2) and H3K9 methylases. The CpG-rich promoters of
development regulators are first recognized by AEBP2 and/or JARID, and subsequently PRC2 is recruited to these target loci, resulting in
trimethylation on H3K27. In contrast, the tandem repeats or retrotransposons are first recognized by YY1 and transcribed by Pol II. The
repeat-driven transcripts are further processed and later used for the targeting of H3K9 methylases, resulting in trimethylation on H3K9 in
the tandem repeats and retrotransposons. Once a given genomic region is marked by H3K27me3 or H3K9me3, that region becomes transcriptionally silent by a series of other follow-up events, including recruitment of PRC1 (H3K27me3) and HP1 (H3K9me3).

Functional Consequences Associated with
Defects in Histone-Modifying Complexes
Genome-wide profiling of the histone marks H3K27me3
and H3K9me3 clearly identify the two different genomic regions that are marked by these modifications, providing immediate hints for the potential functions of these marks at the
genomic level. On the other hand, the biological processes in
which these marks are important can be inferred from the
cellular- and organism-level phenotypes produced by mutations of the histone-modifying complexes responsible for
these marks. According to the results derived from PRC2,
complete or near-complete depletion of the core components
of PRC2 in ES cells usually causes unscheduled differentiation of ES cells, suggesting that PRC2 plays a role in maintaining the pluripotency and self-renewal properties of ES
cells (Margueron and Reinberg 2011; Schuettengruber and
Cavalli 2009). Similar experiments using ES cells were conducted to test the function of H3K9 methylases. Depletion of
SETDB1 causes the induction of several key genes for the
trophectoderm lineage in ES cells, resulting in differentiation into trophectoderm cells (Yeap et al. 2009; Yuan et al.
2009). These results confirm that, besides constitutive heterochromatic regions, many developmental regulators located in euchromatic regions are also subject to the
H3K9-mediated repression (Bilodeau et al. 2009; Lohmann
et al. 2010). Deletion of SETDB1 in ES cells also causes derepression of a large number of endogenous retroviruses,
supporting the fact that many retrotransposons are repressed
by H3K9me3 (Matsui et al. 2010). This is also the case for
KAP-1, an interacting partner of SETDB1: deletion of
KAP-1 in ES cells de-represses a large number of endogenous retroviruses in the mouse genome (Rowe et al. 2010).
In the past decade, the core components of PRC2 and
several H3K9 methylases have been mutated in the mouse,
and subsequently the in vivo roles of these genes have been
analyzed. Results from breeding experiments have shown
that embryos homozygous for the mutant alleles of each
PRC2 component are usually lethal around the implantation
stage, mainly because of a failure to establish the three germ
layers. This suggests that PRC2 is required for lineage specification (Faust et al. 1995; O’Carroll et al. 2001; Pasini et al.
236

2004). The homozygotes for some H3K9 methylase mutants
are also embryonic lethal but at different stages of embryonic development. The homozygotes for SetDB1 die between
3.5 and 5.5 days postcoitum, whereas the homozygotes for
Ehmt2 survive up to 8.5 days postcoitum (Dodge et al. 2004;
Tachibana et al. 2002). In the case of Suv39h1 and Suv39h2,
the homozygotes for single-gene knockouts are viable, but
the double homozygotes for both genes are lethal around
13.5 days postcoitum (Peters et al. 2001). DNA methylation
analyses with these surviving embryos revealed that the pericentromeric repeats are hypomethylated, further supporting the close association between these H3K9 methylases
and DNA methylation machineries. The homozygotes for
Ehmt2, Suv39h1, and Suv39h2 show embryonic lethality
at relatively later stages than those for PRC2, potentially
caused by functional redundancy between different H3K9
methylases. On the other hand, the heterozygotes for the
mutants described above are usually viable within the
Mendelian ratios, but some fraction of these heterozygotes
also show visible phenotypes, such as reduced growth rates
and defects in neurulation (Miró et al. 2009). However, the
actual causes for these phenotypes are currently unknown.
In placental mammals, H3K27me3 and H3K9me3 histone modification marks are also part of the main repression
mechanisms for genomic imprinting and X chromosome inactivation. First, in genomic imprinting, small genomic regions function as imprinting control regions, which control
the allele-specific expression and DNA methylation of the
surrounding imprinted genes (Bartolomei 2009). Interestingly, the known imprinting control regions tend to show
tandem repeat structures (Kim 2008) and, furthermore, are
marked by H3K9me3 in ES cells (Mikkelsen et al. 2007).
This is very unusual because many CpG-rich promoter regions are usually marked by H3K4me3 and/or H3K27me3
in ES cells (Mikkelsen et al. 2007). Nevertheless, it is interesting to point out the presence of a similar pattern, tandem
repeats with H3K9me3, between the imprinting control regions of imprinted regions and the tandem repeats of heterochromatic regions. It is unclear which proteins are responsible
for establishing this histone modification on the known imprinting control regions. However, two H3K9 methylases are
likely involved based on the following observations. RNAibased knockdown of SETDB1 results in the removal of
H3K9me3 and subsequent induction of several imprinted
genes in ES cells, suggesting potential roles for SETDB1 in
genomic imprinting (Yuan et al. 2009). Also, EHMT2 has
been shown to be involved in setting up H3K9me3 on the
Igf2r- and Kcnq1-imprinted domains, which is again required for maintaining the imprinting of these two domains
(Nagano et al. 2008; Redrup et al. 2009). Second, a large
fraction of imprinted genes are imprinted only in the placenta, yet these genes are usually marked with allele-specific
H3K27me3, not with DNA methylation (Lewis et al. 2004;
Umlauf et al. 2004). This observation was first noticed in the
mutant mice targeting Eed (Mager et al. 2003). Many imprinted genes in the Eed mutant are deregulated in terms of
their allele-specific expression, consistent with the fact that
ILAR Journal
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are required for the targeting of PRC2 and subsequent
H3K27me3 establishment. In fact, EZH2 has been shown to
be the protein that interacts with these ncRNAs (Zhao et al.
2008). Similar observations have also been derived for one
H3K9 methylase, EHMT2. According to the results from
two imprinted loci, Igf2r and Kcnq1, the ncRNAs from these
imprinted loci are also required for the targeting of EHMT2
and subsequent establishment of the allele-specific H3K9me3
(Nagano et al. 2008; Redrup et al. 2009). In summary, these
observations suggest that there are likely multiple potential
targeting mechanisms for PRC2 and H3K9 methylases and
they potentially act through both DNA-binding proteins and
ncRNAs.

important questions for these proteins are: (1) Are these proteins responsible for the targeting of PRC2 and H3K9 methylases? If so, then (2) what are the exact functions of each of
these proteins for the histone-modifying complexes? Second,
although the two histone marks have been mainly recognized
as transcription repressors, these marks might have some
functions other than transcription. For instance, H3K9me3 is
mainly detected in the genomic regions with tandem repeats,
which are well known for duplication through crossover. The
H3K9me3-mediated heterochromatin formation might be
designed for blocking potential illegitimate crossover to
preserve genomic stability. This possibility was previously noticed in the phenotype of the Suv39h1 and Suv39h2 mutant
mice, which exhibit a high degree of genomic instability
(Peters et al. 2001). Third, recent data from personal genome
sequencing indicate that many human disorders tend to have
mutations on the genes that are involved in epigenetic setting
(Ernst et al. 2010). Although the homozygotes for any mutation in PRC2 and H3K9 methylases are not viable, as demonstrated in several mouse models, the heterozygotes for these
mutations are likely viable and display altered phenotypes. In
this regard, it is important to note that there are many adult
stem cells that require the function of PRC2 for their pluripotency and self-renewal properties. In a heterozygous individual with a mutation, suboptimal levels of enzymatic activity
for either H3K27me3 or H3K9me3 modification could easily
cause disease states for this very vulnerable population of
adult stem cells. In summary, although we need to wait for
more data from the future experiments described above, it is
very clear that these two histone modification marks are major
repression signals in the development processes of humans
and other mammals.
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